|
|
|
Friday, February 3, 2012
|
Prometheus Announces New Chief Commercial Officer
HSMN NewsFeed,
3 Feb 2012:
Diagnostics, Personnel
[Prometheus Laboratories]
|
Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
HSMN NewsFeed,
3 Feb 2012:
Biopharmaceuticals, Oncology
[Threshold Pharmaceuticals, Merck KGaA, TH-302, soft tissue sarcoma]
|
Caris Diagnostics Announces Name Change to Miraca Life Sciences
HSMN NewsFeed,
3 Feb 2012:
Diagnostics
[Miraca Life Sciences, Caris Diagnostics]
|
Ronnie Andrews Joins Life Technologies as President, Medical Sciences
HSMN NewsFeed,
2 Feb 2012:
Diagnostics, Personnel
[Life Technologies]
|
Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis
HSMN NewsFeed,
2 Feb 2012:
Devices, Interventional
[Spectranetics, PATENT study, peripheral in-stent restenosis, laser atherectomy]
|
Syneron Announces New Ground Breaking evolastin™ Procedure
HSMN NewsFeed,
2 Feb 2012:
Devices, Dermatology
[Syneron Medical, evolastin procedure]
|
EUSA Pharma Acquires Development and Commercialization Rights to ASPAREC(R) for Treatment of Acute Lymphoblastic Leukemia from Alizé Pharma
HSMN NewsFeed,
2 Feb 2012:
Biopharmaceuticals, Oncology, Acquisitions
[EUSA Pharma, Alizé Pharma, ASPAREC , acute lymphoblastic leukemia]
|
Boston Scientific Announces First Implant and Market Launch of PROMUS Element(TM) Plus Stent System in Europe
HSMN NewsFeed,
1 Feb 2012:
Devices, Interventional Cardiology
[Boston Scientific, PROMUS Element, Platinum Chromium, drug eluting stent]
|
TearScience Achieves FDA Clearance for Second Generation LipiFlow(R) Thermal Pulsation System
HSMN NewsFeed,
1 Feb 2012:
Devices, Ophthalmology, FDA
[TearScience, LipiFlow, Thermal Pulsation System, dry eye]
|
Dendreon Announces CEO and Chairman Succession Plan
HSMN NewsFeed,
1 Feb 2012:
Biopharmaceuticals, Personnel
[Dendreon]
|
Toshiba’s Aquilion PRIME CT System Receives FDA Clearance
HSMN NewsFeed,
1 Feb 2012:
Devices, Radiology, FDA
[Toshiba America Medical Systems, Aquilion PRIME]
|
FDA approves Novartis drug Gleevec(R) label recommending extending treatment to three years for certain GIST patients after surgery
HSMN NewsFeed,
1 Feb 2012:
Biopharmaceuticals, Oncology, FDA
[Novartis, Gleevec, imatinib, gastrointestinal stromal tumor]
|
CartiHeal Raises $5 Million in Financing to Support Agili-C For Single Stage Arthroscopic Cartilage Regeneration
HSMN NewsFeed,
1 Feb 2012:
Devices, Orthopaedic, Venture Capital
[CartiHeal, Agili-C, Cartilage Regeneration]
|
ISO 9001:2008 and ISO 13485:2003 Certifications for Vita Needle Company
HSMN NewsFeed,
31 Jan 2012:
Devices, Regulatory
[Vita Needle]
|
Cardinal Health Introduces Smart-Seal(TM) Surgical Mask
HSMN NewsFeed,
31 Jan 2012:
Devices, Surgery
[Cardinal Health, Smart-Seal, surgical mask]
|
AngioDynamics to Acquire Navilyst Medical for $372 Million
HSMN NewsFeed,
31 Jan 2012:
Devices, Mergers & Acquisitions
[AngioDynamics, Navilyst Medical]
|
Sorin Group Launches a New Complete Portfolio of Pacing, Defibrillation and Left Ventricular Leads
HSMN NewsFeed,
31 Jan 2012:
Devices, Cardiology, Regulatory
[Sorin Group, pacing leads, TILDA pacing leads, VIGILA defibrillation leads]
|
New Clinical Study Finds Use of Tissuemed's Sealant Film TissuePatchDural "Encouraging" in Prevention of CSF Leaks
HSMN NewsFeed,
31 Jan 2012:
Devices, Neurosurgery
[Tissuemed, dural sealant film, TissuePatchDural]
|
Hospira Names Richard Davies Chief Commercial Officer
HSMN NewsFeed,
30 Jan 2012:
Biopharmaceuticals, Drug Delivery, Personnel
[Hospira]
|
Physio-Control Completes Sale to Bain Capital
HSMN NewsFeed,
30 Jan 2012:
Devices, Mergers & Acquisitions
[Physio-Control, Bain Capital]
|
ImmunoGen, Inc. Announces Addition of Kristine Peterson and Dean Mitchell to Its Board of Directors
HSMN NewsFeed,
30 Jan 2012:
Biopharmaceuticals, Oncology, Personnel
[ImmunoGen]
|
Curis Announces FDA Approval of Erivedge(TM) (vismodegib) Capsule as First Treatment for Advanced Basal Cell Carcinoma
HSMN NewsFeed,
30 Jan 2012:
Biopharmaceuticals, Oncology, FDA
[Curis, Erivedge, vismodegib, basal cell carcinoma]
|
CardioKinetix Receives Expanded CE Mark Approval for World's First Percutaneous Left Ventricular Partitioning Device, the Parachute(TM), for Treatment of Ischemic Heart Failure
HSMN NewsFeed,
30 Jan 2012:
Devices, Cardiology, Regulatory
[CardioKinetix, Parachute, Ventricular Partitioning Device, heart failure]
|
Baxter Announces FDA Approval of Expanded Indication for TISSEEL [Fibrin Sealant] for General Hemostasis in Surgery
HSMN NewsFeed,
30 Jan 2012:
Devices, Surgery, FDA
[Baxter International, TISSEEL, Fibrin Sealant, hemostasis]
|
Cardinal Health and Cook Medical Announce Exclusive Agreement for Customizable Vascular Access Kitting Solution
HSMN NewsFeed,
30 Jan 2012:
Devices, Distribution
[Cook Medical, Cardinal Health, CVC procedural kits]
|
Medtronic Announces FDA Approval of DF4 High-Voltage Connector System for Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Devices
HSMN NewsFeed,
30 Jan 2012:
Devices, Cardiology, FDA
[Medtronic, DF4 High-Voltage Connector System, CRT-D]
|
ConforMIS Reaches Funding Milestone with $89 Million in Series E Financing
HSMN NewsFeed,
30 Jan 2012:
Devices, Venture Capital
[ConforMIS]
|
Intellipharmaceutics Appoints Vice President Business Development
HSMN NewsFeed,
30 Jan 2012:
Biopharmaceuticals, Generics, Personnel
[Intellipharmaceutics International]
|
EDAP Regains Ablatherm(R)-HIFU Distribution Rights in Canada and Caribbean
HSMN NewsFeed,
30 Jan 2012:
Devices, Distribution
[EDAP TMS, Ablatherm, HIFU]
|
Cynosure Receives FDA 510(k) Clearance for Cellulaze Cellulite Laser Workstation
HSMN NewsFeed,
30 Jan 2012:
Devices, Dermatology, FDA
[Cynosure, Cellulaze, cellulite]
|
Biogen Idec Appoints Kenneth DiPietro Executive Vice President, Human Resources
HSMN NewsFeed,
30 Jan 2012:
Biopharmaceuticals, Personnel
[Biogen Idec]
|
Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Trial; Investigational Device Exemption (IDE) Approved for ATHENA
HSMN NewsFeed,
30 Jan 2012:
Regenerative Medicine, Cardiology
[Cytori Therapeutics, ATHENA trial, Celution System, chronic myocardial ischemia]
|
Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc.
HSMN NewsFeed,
30 Jan 2012:
Biopharmaceuticals
[Valeant Pharmaceuticals International, ISTA Pharmaceuticals]
|
Covidien Revascularization Device Approved for Interventional Management of Stroke Trial
HSMN NewsFeed,
30 Jan 2012:
Devices, Interventional, Neurology
[Covidien, Solitaire FR, Revascularization Device, stroke]
|
Wright Medical Group, Inc. Names Daniel Garen Senior Vice President and Chief Compliance Officer
HSMN NewsFeed,
30 Jan 2012:
Devices, Orthopaedic, Personnel
[Wright Medical Group]
|
Fourth German Hospital Selects IntraOp Medical Corporation’s Mobetron
HSMN NewsFeed,
30 Jan 2012:
Devices, Oncology
[IntraOp Medical, Mobetron, IOERT]
|
Cell Therapeutics Withdraws New Drug Application for Pixuvri™ and Plans to Resubmit in 2012
HSMN NewsFeed,
30 Jan 2012:
Biopharmaceuticals, Oncology
[Cell Therapeutics, Pixuvri, pixantrone, non-Hodgkin's lymphoma]
|
Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera(R) Marketing Authorisation and Requests Further Information From the CHMP
HSMN NewsFeed,
30 Jan 2012:
Biopharmaceuticals, Regulatory
[Amsterdam Molecular Therapeutics, Glybera, alipogene tiparvovec, LPLD]
|
|
|
|
|
Public
Feeds 
Full text >>